Natera (NASDAQ:NTRA) Given New $205.00 Price Target at Piper Sandler
Natera (NASDAQ:NTRA – Free Report) had its target price upped by Piper Sandler from $200.00 to $205.00 in a research report sent to investors on Tuesday,Benzinga reports. They currently have an overweight rating on the medical research company’s stock. Several other research analysts have also recently issued reports on NTRA. StockNews.com cut Natera from a […]
